Biotia raises $9 million to expand metagenomics testing, advance reimbursement, and broaden diagnostics in women’s health and ...
A study found the AidaBREAST test can assess 10-year recurrence risk and predict radiation therapy benefit in early-stage ...
China’s NMPA has approved Quanterix and Innovita’s HD-X and SR-X instruments and four blood-based neurology assays for use in ...
Clinisys adds document intelligence to its Laboratory Solution, enabling labs to convert documents into searchable, governed ...
A study demonstrates correlation between measurements of biologically active ET-1 generated using Olink proximity extension ...
Roche supplied two molecular testing systems and in the DRC to support PCR test validation for Bundibugyo virus amid Ebola outbreak.
A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...
Astrin Biosciences' Certitude blood test for supplemental breast cancer screening is now available to eligible women across ...
Cerenome's CNSide Diagnostics launched two CSF-based molecular profiling tests for CNS cancers, analyzing DNA and RNA.
A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.
Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with consumables and ...
A phase III trial ancillary analysis found the Decipher Prostate Test predicts which intermediate-risk prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results